Nelfinavir induces radiation sensitization in pituitary adenoma cells

Jing Zeng, Alfred P. See, Khaled Aziz, Saravanan Thiyagarajan, Tarek Salih, Rajendra P. Gajula, Michael Armour, Jillian Phallen, Stephanie Terezakis, Lawrence Kleinberg, Kristen Redmond, Russell K. Hales, Roberto Salvatori, Alfredo Quinones-Hinojosa, Phuoc T. Tran, Michael Lim

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

Pituitary adenomas with local invasion and high secretory activity remain a therapeutic challenge. The HIV protease inhibitor nelfinavir is a radiosensitizer in multiple tumor models. We tested nelfinavir as a radiosensitizer in pituitary adenoma cells in vitro and in vivo. We examined the effect of nelfinavir with radiation on in vitro cell viability, clonogenic survival, apoptosis, prolactin secretion, cell cycle distribution and the PI3K-AKT-mTOR pathway. We evaluated tumor growth delay and confirmed nelfinavir's effect on the PI3K-AKT-mTOR pathway in a hind-flank model. Nelfinavir sensitized pituitary adenoma cells to ionizing radiation as shown by viability assays and clonogenic assay with an enhancement ratio of 1.2 (p < 0.05). There is increased apoptotic cell death, as determined by annexin-V expression and cleaved caspase-3 levels. Nelfinavir does not affect prolactin secretion or cell cycle distribution. In vivo, untreated tumors reached 4-fold volume in 12 d, 17 d with nelfinavir treatment, 27 d with radiation 6 Gy, and 41 d with nelfinavir plus radiation (one-way ANOVA p < 0.001). Decreased phospho-S6 on protein gel blotting in vitro and immunohistochemistry in vivo demonstrated nelfinavir inhibition of the PI3K-AKT-mTOR pathway. Our data suggests a promising combination therapy with nelfinavir plus radiation in pituitary adenomas, which should be investigated in clinical studies.

Original languageEnglish (US)
Pages (from-to)657-663
Number of pages7
JournalCancer Biology and Therapy
Volume12
Issue number7
DOIs
StatePublished - Oct 1 2011
Externally publishedYes

Bibliographical note

Funding Information:
using the Mouse/Rat Prolactin ELISA kit from Calbiotech T.S. was supported by the Johns Hopkins Post-baccalaureate (PR063F100) as described by the manufacturer with GH3 Research Education Program. P.T.T. was supported by the Parker cells plated into 96 well plates. All experiments were done in B. Francis Fellowship and the ASTRO Junior Faculty Career duplicates. Research Training Award.

Keywords

  • Nelfinavir
  • PI3K-AKT-mTOR
  • Pituitary adenomas
  • Radiosensitizer

Fingerprint

Dive into the research topics of 'Nelfinavir induces radiation sensitization in pituitary adenoma cells'. Together they form a unique fingerprint.

Cite this